Skip to main content

Completion of the Sale of the Share of Saare Kala Tootmine OÜ

AS PRFoods (registry code 11560713) hereby notifies that its subsidiary Saaremere Kala AS (registry code  11310040, hereinafter “Seller“) has completed previously announced transaction (as disclosed in a stock exchange announcement published by AS PRFoods on 23 April 2026 (https://view.news.eu.nasdaq.com/view?id=1436682&lang=en), whereby 100% shareholding in Saare Kala Tootmine OÜ (registry code 10377013, hereinafter “SKT“) was sold and claims arising from shareholder loans and an inventory loan provided to SKT were transferred to the Latvian company Brīvais Vilnis A/S (Latvian registry code: 40003056186, hereinafter “Buyer“). The general meeting of shareholders of AS PRFoods approved the transaction by their relevant resolution published on 18 May 2026 (https://view.news.eu.nasdaq.com/view?id=1442522&lang=en)....

Continue reading

Genco Shipping & Trading Limited Urges Shareholders to Vote Today

Vote for All of Genco’s Highly Qualified Directors in Line with Recommendations of Three Proxy Advisory Firms Genco’s Board of Directors Is Delivering Superior Returns and Value to Shareholders Through Execution of Genco’s Comprehensive Value Strategy Additional Information Available at www.GencoDrivesSuperiorReturns.com NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today mailed a communication to shareholders urging them to vote FOR ALL of Genco’s highly qualified directors on the WHITE proxy card and WITHHOLD on both of Diana Shipping Inc.’s (“Diana”) handpicked nominees. Genco issued the following statement:Genco’s Annual Meeting is fast approaching,...

Continue reading

Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy 

Ecopipam, an investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan Drug and Fast Track designations.  The acquisition expands Teva’s innovative pipeline in a specialized area of neuroscience with significant unmet need and is expected to support near- and long-term growth.  At closing, Teva paid $700 million consideration with the potential for up to an additional $200 million in commercial milestone payments, as well as net sales-based royalties, upon commercialization and subject to regulatory approval. TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the closing of Teva’s acquisition of Emalex Biosciences, strengthening...

Continue reading

SOITEC – AVAILABILITY OF THE 2025-2026 UNIVERSAL REGISTRATION DOCUMENT

AVAILABILITY OF THE 2025-2026 UNIVERSAL REGISTRATION DOCUMENT Bernin (Grenoble), France, June 10, 2026 – Soitec (Euronext Paris) announces the filing today of its 2025-2026 Universal Registration Document in ESEF format (European Single Electronic Format) with the French Financial Markets Authority (Autorité des Marchés Financiers – AMF). The 2025-2026 Universal Registration Document is made available to the public in compliance with applicable laws and regulations and can be consulted in French and in English on the Company’s website (www.soitec.com) under the section Investors – Regulated Information – Financial Reports, results & other regulated releases. The French version is also available on the AMF website (www.amf-france.org). The 2025-2026 Universal Registration Document, which includes the Annual Financial Report, contains...

Continue reading

Societe Generale: shares and voting rights as of 31 May 2026

NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 31 MAY 2026 Regulated Information Paris, 10 June 2026 Information about the total number of voting rights and shares pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulations.Date Number of shares composing current share capital Total number ofvoting rights31 May 2026744,394,214  Gross: 829,640,869Press contacts: Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.comFanny Rouby_+33 1 57 29 11 12_ fanny.rouby@socgen.com Societe Generale Societe Generale is a top-tier European Bank with around 110,000 employees serving 27 million clients in 58 countries across the world. We have been supporting the development of our economies for over 160 years, providing our...

Continue reading

Cabka Shareholders Approve All Resolutions at Annual General Meeting 2026

Amsterdam, 10 June 2026. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard-to-recycle plastic waste into innovative Reusable Transport Packaging (RTP), announces that its shareholders approved all proposals at its Annual General Meeting today, including the adoption of the 2025 financial statements and the appropriation of the net result. Key highlights include:Niek Hoek was reappointed as a member of the Supervisory Board for a four-year term and continues as Chair. Gat Ramon, Stephan Nanninga and Jeanine Holscher were reappointed to the Supervisory Board for four-year terms. Anja Siegesmund was appointed to the Supervisory Board for a four-year term, having served as an interim member since May 2025, and joins the Audit Committee. The 2025 Remuneration Report was endorsed...

Continue reading

Dalfen Industrial Accelerates Southeast Expansion with Fort Lauderdale Portfolio Acquisition

Broward County, FLDalfen Industrial Accelerates Southeast Expansion with Fort Lauderdale Portfolio AcquisitionDALLAS, June 10, 2026 (GLOBE NEWSWIRE) — Dalfen Industrial has acquired a nine-building industrial portfolio totaling 419,253 square feet in Broward County, Florida, further strengthening the company’s presence in one of the nation’s most sought-after infill logistics markets. Acquired at 55% replacement cost, the Broward Logistics Portfolio is currently 83% leased to nine tenants including FedEx, Event Service Group Realestate, LLC, Chromalloy Material Solutions, LLC, and Commercial Distribution Specialists, Inc. The portfolio features buildings ranging from 10,000 – 68,500 square feet, offering flexibility for a wide range of industrial users. Strategically positioned with direct access to Interstate 95 and the...

Continue reading

Fnac Darty: Notice new OCEANE conversion ratio during the offer period

Ivry-sur-Seine – France, June 10, 2026 Notice to holders of the € 199,999,947.63 bonds convertible into new shares and/or exchangeable for existing shares (OCEANE) due March 2027 of Fnac Darty (ISIN FR0014002JO2) (the “Bonds”) Capitalised terms not otherwise defined in this notice shall have the meaning given to them in theterms and conditions of the Bonds (the “Conditions”). Further to the notice dated 11 May 2026, Bondholders are hereby notified that, as a result of the adjustment to the Conversion/Exchange Ratio pursuant to the notice dated 5 June 2026, illustratively, based on the Conversion/Exchange Ratio currently in effect of 1.201 Fnac Darty shares per each Bond (in the principal amount of €81.03 each), the Public Offer Conversion/Exchange Ratio based on such Conversion/Exchange Ratio would therefore be 1.287 Fnac Darty shares...

Continue reading

VINCI: Disclosure of transactions in on shares from June 1st to June 5th,2026

Nanterre, June 10th, 2026                      Disclosure of transactions in on shares from June 1st to June 5th, 2026 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 14th, 2026, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from June 1st to June 5th,2026: I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 01/06/2026 FR0000125486 8 543 122,8079 AQEUVINCI 01/06/2026 FR0000125486 35 705 122,9745 CEUXVINCI 01/06/2026 FR0000125486 11...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.